Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Cancer immunotherapy company EpicentRx raises $35m in Series D round EpicentRx, a cancer immunotherapy company based in California, has secured $35 million of capital through a Series D… bypharmanewsdailyNovember 14, 2019